7/19/16
The July 2016 Pediatrics reported safety data from 7 phase 3 clinical trials. The meta analysis on the HPV 9 vaccine, known in the United States as Gardasil®9 (manufactured by Merck) showed the vaccine is well tolerated in 9-26 year old males and females. This additional safety data should only enhance parental confidence in providing this essential cancer prevention vaccine for their teens.